• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors.若丹宁作为开发广谱金属β-内酰胺酶抑制剂的有效骨架。
ACS Med Chem Lett. 2018 Mar 22;9(4):359-364. doi: 10.1021/acsmedchemlett.7b00548. eCollection 2018 Apr 12.
2
Dihydroxyphenyl-substituted thiosemicarbazone: A potent scaffold for the development of metallo-β-lactamases inhibitors and antimicrobial.二羟基苯基取代的硫代半卡巴腙:一种用于开发金属β-内酰胺酶抑制剂和抗菌剂的有效骨架。
Bioorg Chem. 2022 Oct;127:105928. doi: 10.1016/j.bioorg.2022.105928. Epub 2022 Jun 13.
3
Hydroxamic acid with benzenesulfonamide: An effective scaffold for the development of broad-spectrum metallo-β-lactamase inhibitors.羟肟酸与苯磺酰胺:开发广谱金属β-内酰胺酶抑制剂的有效支架。
Bioorg Chem. 2020 Dec;105:104436. doi: 10.1016/j.bioorg.2020.104436. Epub 2020 Oct 29.
4
Amino Acid Thioesters Exhibit Inhibitory Activity against B1-B3 Subclasses of Metallo-β-lactamases.氨基酸硫酯对金属β-内酰胺酶的B1-B3亚类具有抑制活性。
Chem Pharm Bull (Tokyo). 2019;67(2):135-142. doi: 10.1248/cpb.c18-00717.
5
Dithiocarbamate as a Valuable Scaffold for the Inhibition of Metallo-β-Lactmases.二硫代氨基甲酸盐作为抑制金属β-内酰胺酶的有价值的支架。
Biomolecules. 2019 Nov 5;9(11):699. doi: 10.3390/biom9110699.
6
Amino Acid Thioester Derivatives: A Highly Promising Scaffold for the Development of Metallo-β-lactamase L1 Inhibitors.氨基酸硫酯衍生物:一种用于开发金属β-内酰胺酶L1抑制剂的极具潜力的骨架。
ACS Med Chem Lett. 2015 Apr 23;6(6):660-4. doi: 10.1021/acsmedchemlett.5b00098. eCollection 2015 Jun 11.
7
Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.唑硫代乙酰胺:一种极具开发金属β-内酰胺酶抑制剂潜力的骨架结构。
ACS Med Chem Lett. 2015 Feb 12;6(4):455-60. doi: 10.1021/ml500534c. eCollection 2015 Apr 9.
8
Dipyridyl-substituted thiosemicarbazone as a potent broad-spectrum inhibitor of metallo-β-lactamases.二吡啶基取代的硫代缩氨基脲作为一种有效的广谱金属-β-内酰胺酶抑制剂。
Bioorg Med Chem. 2021 May 15;38:116128. doi: 10.1016/j.bmc.2021.116128. Epub 2021 Apr 8.
9
Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.唑硫基乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5225-5229. doi: 10.1016/j.bmcl.2017.10.038. Epub 2017 Oct 20.
10
Halogen-Substituted Triazolethioacetamides as a Potent Skeleton for the Development of Metallo-β-Lactamase Inhibitors.卤代三唑硫代乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Molecules. 2019 Mar 25;24(6):1174. doi: 10.3390/molecules24061174.

引用本文的文献

1
Approachable Synthetic Methodologies for Second-Generation -Lactamase Inhibitors: A Review.第二代β-内酰胺酶抑制剂的便捷合成方法:综述
Pharmaceuticals (Basel). 2024 Aug 23;17(9):1108. doi: 10.3390/ph17091108.
2
Rhodanine derived enethiols react to give 1,3-dithiolanes and mixed disulfides.罗丹宁衍生的烯硫醇反应生成1,3-二硫戊环和混合二硫化物。
RSC Med Chem. 2024 Jun 5;15(7):2305-2309. doi: 10.1039/d4md00157e. eCollection 2024 Jul 17.
3
In Vitro and In Vivo Development of a β-Lactam-Metallo-β-Lactamase Inhibitor: Targeting Carbapenem-Resistant .β-内酰胺-金属β-内酰胺酶抑制剂的体外和体内研究:针对碳青霉烯类耐药菌。
ACS Infect Dis. 2023 Mar 10;9(3):486-496. doi: 10.1021/acsinfecdis.2c00485. Epub 2023 Feb 14.
4
Towards combating antibiotic resistance by exploring the quantitative structure-activity relationship of NDM-1 inhibitors.通过探索NDM-1抑制剂的定量构效关系来对抗抗生素耐药性。
EXCLI J. 2022 Nov 16;21:1331-1351. doi: 10.17179/excli2022-5380. eCollection 2022.
5
Synthesis, Biological Evaluation and Molecular Docking Studies of 5-Indolylmethylen-4-oxo-2-thioxothiazolidine Derivatives.5-吲哚亚甲基-4-氧代-2-硫代噻唑烷衍生物的合成、生物评价及分子对接研究。
Molecules. 2022 Feb 5;27(3):1068. doi: 10.3390/molecules27031068.
6
Enzyme Inhibitors: The Best Strategy to Tackle Superbug NDM-1 and Its Variants.酶抑制剂:应对超级细菌 NDM-1 及其变体的最佳策略。
Int J Mol Sci. 2021 Dec 24;23(1):197. doi: 10.3390/ijms23010197.
7
Metallo-β-lactamases in the Age of Multidrug Resistance: From Structure and Mechanism to Evolution, Dissemination, and Inhibitor Design.金属β-内酰胺酶在多药耐药时代:从结构和机制到进化、传播和抑制剂设计。
Chem Rev. 2021 Jul 14;121(13):7957-8094. doi: 10.1021/acs.chemrev.1c00138. Epub 2021 Jun 15.
8
Ebsulfur and Ebselen as highly potent scaffolds for the development of potential SARS-CoV-2 antivirals.埃布硫和依布硒仑作为开发潜在的抗新冠病毒药物的高效骨架。
Bioorg Chem. 2021 Jul;112:104889. doi: 10.1016/j.bioorg.2021.104889. Epub 2021 Apr 8.
9
Metallo-β-Lactamase Inhibitors Inspired on Snapshots from the Catalytic Mechanism.基于催化机制快照得到的金属-β-内酰胺酶抑制剂
Biomolecules. 2020 Jun 3;10(6):854. doi: 10.3390/biom10060854.
10
Discovery of the Novel Inhibitor Against New Delhi Metallo-β-Lactamase Based on Virtual Screening and Molecular Modelling.基于虚拟筛选和分子建模发现新型抗新德里金属β-内酰胺酶抑制剂。
Int J Mol Sci. 2020 May 18;21(10):3567. doi: 10.3390/ijms21103567.

本文引用的文献

1
Azolylthioacetamides as a potent scaffold for the development of metallo-β-lactamase inhibitors.唑硫基乙酰胺作为开发金属β-内酰胺酶抑制剂的有效骨架。
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5225-5229. doi: 10.1016/j.bmcl.2017.10.038. Epub 2017 Oct 20.
2
The structure of the metallo-β-lactamase VIM-2 in complex with a triazolylthioacetamide inhibitor.金属β-内酰胺酶VIM-2与三唑基硫代乙酰胺抑制剂复合物的结构。
Acta Crystallogr F Struct Biol Commun. 2016 Nov 1;72(Pt 11):813-819. doi: 10.1107/S2053230X16016113. Epub 2016 Oct 24.
3
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronates.环状硼酸酯抑制金属β-内酰胺酶、丝氨酸β-内酰胺酶和青霉素结合蛋白的结构基础。
Nat Commun. 2016 Aug 8;7:12406. doi: 10.1038/ncomms12406.
4
Elucidating the Role of Residue 67 in IMP-Type Metallo-β-Lactamase Evolution.阐明67位残基在IMP型金属β-内酰胺酶进化中的作用。
Antimicrob Agents Chemother. 2015 Dec;59(12):7299-307. doi: 10.1128/AAC.01651-15. Epub 2015 Sep 14.
5
Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1).依布硒啉作为新型德里金属β-内酰胺酶(NDM-1)的强效共价抑制剂。
Chem Commun (Camb). 2015 Jun 11;51(46):9543-6. doi: 10.1039/c5cc02594j.
6
Rhodanine hydrolysis leads to potent thioenolate mediated metallo-β-lactamase inhibition.雷琐辛水解导致有效的硫代烯醇化物介导的金属β-内酰胺酶抑制。
Nat Chem. 2014 Dec;6(12):1084-90. doi: 10.1038/nchem.2110. Epub 2014 Nov 17.
7
Biochemical, mechanistic, and spectroscopic characterization of metallo-β-lactamase VIM-2.金属β-内酰胺酶VIM-2的生化、机制及光谱特征分析
Biochemistry. 2014 Nov 25;53(46):7321-31. doi: 10.1021/bi500916y. Epub 2014 Nov 13.
8
Aspergillomarasmine A overcomes metallo-β-lactamase antibiotic resistance.aspergillomarasmine A 克服金属β-内酰胺酶抗生素耐药性。
Nature. 2014 Jun 26;510(7506):503-6. doi: 10.1038/nature13445.
9
Asp120Asn mutation impairs the catalytic activity of NDM-1 metallo-β-lactamase: experimental and computational study.Asp120Asn 突变使 NDM-1 金属β-内酰胺酶的催化活性受损:实验和计算研究。
Phys Chem Chem Phys. 2014 Apr 14;16(14):6709-16. doi: 10.1039/c3cp55069a. Epub 2014 Mar 3.
10
The ABCD's of β-lactamase nomenclature.β-内酰胺酶命名法的 ABCD。
J Infect Chemother. 2013 Aug;19(4):549-59. doi: 10.1007/s10156-013-0640-7. Epub 2013 Jul 5.

若丹宁作为开发广谱金属β-内酰胺酶抑制剂的有效骨架。

Rhodanine as a Potent Scaffold for the Development of Broad-Spectrum Metallo-β-lactamase Inhibitors.

作者信息

Xiang Yang, Chen Cheng, Wang Wen-Ming, Xu Li-Wei, Yang Ke-Wu, Oelschlaeger Peter, He Yuan

机构信息

Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education, Chemical Biology Innovation Laboratory, College of Chemistry and Materials Science, Northwest University, Xi'an 710127, P. R. China.

Department of Pharmaceutical Sciences, College of Pharmacy, Western University of Health Sciences, 309 East Second Street, Pomona, California 91766, United States.

出版信息

ACS Med Chem Lett. 2018 Mar 22;9(4):359-364. doi: 10.1021/acsmedchemlett.7b00548. eCollection 2018 Apr 12.

DOI:10.1021/acsmedchemlett.7b00548
PMID:29670701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5900329/
Abstract

A series of rhodanines was constructed, their Z-configuration was confirmed by small molecule X-ray crystal structures, and their activity against metallo-β-lactamases (MβLs) was measured. The obtained 26 molecules and a thioenolate specifically inhibited the MβL L1 with an IC range of 0.02-1.7 μM, and compounds - exhibited broad-spectrum inhibition of the MβLs NDM-1, VIM-2, ImiS, and L1 with IC values <16 μM. All inhibitors increased the antimicrobial effect of cefazolin against cells expressing L1, resulting in a 2-8-fold reduction in MIC. Docking studies suggested that the nitro (NDM-1, CphA, and L1) or carboxyl group (VIM-2) of coordinates one or two Zn(II) ions, while the -phenyl group of the inhibitor enhances its hydrophobic interaction with MβLs. These studies demonstrate that the diaryl-substituted rhodanines are good scaffolds for the design of future broad-spectrum inhibitors of MβLs.

摘要

构建了一系列若丹宁,通过小分子X射线晶体结构确认了它们的Z构型,并测定了它们对金属β-内酰胺酶(MβLs)的活性。所得到的26个分子和一种硫醇盐特异性抑制MβL L1,IC范围为0.02 - 1.7 μM,并且化合物对MβLs NDM-1、VIM-2、ImiS和L1表现出广谱抑制,IC值<16 μM。所有抑制剂均增强了头孢唑林对表达L1的细胞的抗菌作用,导致MIC降低2 - 8倍。对接研究表明,的硝基(NDM-1、CphA和L1)或羧基(VIM-2)与一个或两个Zn(II)离子配位,而抑制剂的-苯基增强了其与MβLs的疏水相互作用。这些研究表明,二芳基取代的若丹宁是设计未来MβLs广谱抑制剂的良好支架。